Overview

A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia

Status:
Withdrawn
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and effect of ORTD-1 on COVID-19 related pneumonia.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Oryn Therapeutics, LLC